Double-blind comparison of the analgesic response to oral ciramadol (WY-15.705) and pentazocine in post-operative pain
- 1 January 1981
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 19 (4) , 259-262
- https://doi.org/10.1007/bf00562802
Abstract
The efficacy and safety of oral ciramadol, a synthetic partial agonist-antagonist analgesic, in rapid control of postoperative pain was compared with oral pentazocine in a double blind study in 46 patients. Ciramadol 20 mg and 60 mg and pentazocine 50 mg had a rapid analgesic effect, peaking within one hour. Although a similar pattern of activity was observed for ciramadol 20 mg and pentazocine 50 mg, ciramadol 60 mg provided significantly better and longer lasting pain relief (P<0.02). Side effects included sedation and sweating, which occurred with a similar frequency in the various treatment groups. Oral ciramadol appears to be a safe and highly effective analgesic.This publication has 6 references indexed in Scilit:
- Analgesic effect of ciramadol in patients with chronic painCurrent Medical Research and Opinion, 1980
- A potent benzylamine analgesic:(−)cis-2(α-dimethylamino-m-hydroxybenzyl)cyclohexanolCellular and Molecular Life Sciences, 1978
- INFLUENCE OF ANAESTHETIC TECHNIQUE ON POSTOPERATIVE PAIN: A comparison of anaesthetic supplementation with halothane and with phenoperidineBritish Journal of Anaesthesia, 1976
- PentazocineDrugs, 1973
- A comparison of the analgesic effects of pentazocine and morphine in patients with cancerClinical Pharmacology & Therapeutics, 1966
- Oral analgesic studies: Pentazocine hydrochloride, codeine, aspirin, and placebo and their influence on response to placeboClinical Pharmacology & Therapeutics, 1966